Floatz logo

Therapeutic Asset Ratings

124 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Ulixertinib
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Taselisib
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2CCC (51)
Atezolizumab
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP1/2CCC (50)
Durvalumab
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer CenterP1/2CCC (50)
Niraparib
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP1/2CCC (50)
Tuvusertib
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P1/2CCC (50)
Capecitabine
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP1CCC (49)
Irinotecan
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP1CCC (49)
Entinostat
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P1/2CCC (49)
Bms-907351
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer CenterP1CCC (48)
Devimistat
Advanced Malignant Solid Neoplasm
Northwestern UniversityP2CC (47)
FMISO
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2CC (47)
Eribulin
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP1CC (46)
(+)-VINCRISTINE
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP1CC (46)
Axatilimab
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP1/2CC (45)
Decitabine
Advanced Malignant Solid Neoplasm
Roswell Park Cancer InstituteP1/2CC (45)
HAFNIUM OXIDE
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer CenterP1/2CC (45)
Ivuxolimab
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer CenterP1/2CC (45)
Retifanlimab
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP1/2CC (45)
trc102
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P1/2CC (45)
Pamiparib
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer CenterP1CC (44)
Utomilumab
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer CenterP1/2CC (44)
Avelumab
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer CenterP1/2CC (43)
au409
Advanced Malignant Solid Neoplasm
University of Southern CaliforniaP1CC (41)
Axitinib
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer CenterP1CC (41)
Showing 76 to 100 of 124 assets
PreviousPage 4 of 5Next